🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of Tylenol, claiming the corporations hid safety concerns that the medication presented to pediatric cognitive development.

The court filing follows a month after Former President Trump publicized an unverified association between consuming Tylenol - referred to as paracetamol - throughout gestation and autism in young ones.

The attorney general is taking legal action against Johnson & Johnson, which once produced the medication, the sole analgesic suggested for expectant mothers, and the current manufacturer, which currently produces it.

In a official comment, he stated they "misled consumers by making money from discomfort and pushing pills ignoring the risks."

The manufacturer says there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These companies deceived for years, knowingly endangering countless individuals to line their pockets," Paxton, a Republican, declared.

The company said in a statement that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the potential impact that could have on the welfare of American women and children."

On its official site, the company also said it had "consistently assessed the relevant science and there is lacking reliable evidence that shows a verified association between consuming paracetamol and autism."

Organizations representing doctors and healthcare providers concur.

The leading OB-GYN organization has declared acetaminophen - the key substance in Tylenol - is one of the few options for women during pregnancy to manage pain and elevated temperature, which can create serious health risks if not addressed.

"In multiple decades of studies on the use of acetaminophen in gestation, no reliable research has conclusively proven that the usage of acetaminophen in any stage of gestation results in neurodevelopmental disorders in offspring," the association stated.

The court filing references recent announcements from the previous government in claiming the medication is potentially dangerous.

Last month, Trump raised alarms from health experts when he advised pregnant women to "fight like hell" not to take Tylenol when ill.

Federal regulators then released a statement that medical professionals should contemplate reducing the consumption of Tylenol, while also declaring that "a direct connection" between the medication and autism spectrum disorder in minors has not been proven.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had pledged in April to undertake "extensive scientific investigation" that would determine the origin of autism spectrum disorder in a limited time.

But authorities advised that finding a unique factor of autism - thought by researchers to be the result of a complicated interplay of genetic and environmental factors - would prove challenging.

Autism is a type of lifelong neurodivergence and condition that impacts how individuals encounter and interact with the world, and is diagnosed using medical professional evaluations.

In his legal document, Paxton - aligned with the former president who is running for federal office - claims Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the science" around paracetamol and autism.

The case aims to force the companies "eliminate any promotional materials" that asserts acetaminophen is safe for women during pregnancy.

The Texas lawsuit echoes the concerns of a collection of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in recently.

A federal judge dismissed the legal action, stating investigations from the plaintiffs' authorities was lacking definitive proof.